The good old Madam !
As noted - in my opinion.
Point is - you say the Teva R/ship is dubious...fair enough as well because like me its your opinion.
However I say Teva R/ship is solid and thick (based on CEO comments and analyst notes).
And from my point of view, I also say it would make logical sense that the r/ship could be further enhanced with the following announcements:
19/3/2015:
MESOBLAST SELECTED FOR FAST TRACK ACCESS TO POTENTIAL INVESTMENT INCENTIVES IN JAPAN ; and
27/3/2015:
MESOBLAST KEY PATENT ALLOWED IN JAPAN FOR THE TREATMENT OF HEART DISEASES, STROKE, AND OTHER VASCULAR CONDITIONS
Teva have a good presence in Japan and with the support of JETRO - why wouldn't any commercially driven Pharma look to take advantage of the "new" Regenerative Medicine laws in Japan – particularly when there are potentiall significant incentives.
Madam – do you see any negatives in the above 2 announcements ?
DYOR. Above just in my opinion.
GLTAH - 2015
- Forums
- ASX - By Stock
- Trading high volume
The good old Madam ! As noted - in my opinion. Point is - you...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.02 |
Change
0.035(3.57%) |
Mkt cap ! $1.167B |
Open | High | Low | Value | Volume |
$1.01 | $1.04 | 99.0¢ | $2.267M | 2.224M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 95996 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 18925 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 95982 | 1.010 |
11 | 163013 | 1.005 |
12 | 237024 | 1.000 |
5 | 62475 | 0.995 |
13 | 688264 | 0.990 |
Price($) | Vol. | No. |
---|---|---|
1.015 | 19233 | 14 |
1.020 | 62467 | 14 |
1.025 | 111170 | 9 |
1.030 | 67303 | 11 |
1.035 | 56304 | 7 |
Last trade - 11.41am 16/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online